High Flow Therapy in ICUs Across Ibero America

Fundación Santa Fe de Bogota255 enrolled

Overview

The study aims to describe the use of Nasal High Flow (NHF) in the intensive care units of participating centers in Iberoamerica. It will describe the indications for the use, the clinical outcome of patients , and the therapeutic failure of NHF therapy in patients staying in an intensive care unit in the participant centers in Iberoamerica.

Study Type

OBSERVATIONAL

Enrollment

255

Conditions

Nasal High Flow Therapy Intensive Care Unit Ventilatory Failure Hypoxia Hypercapnic Respiratory Failure

Interventions

No interventionOTHER

No intervention, observational study

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Over 18 years old * Admitted to medical or surgical ICU * Requirement of high nasal flow therapy Exclusion Criteria: * Post-extubation failure * Patient unable to protect airway * Diagnosed shock * Glasgow equal or under 8

Locations (9)

Fundación Santa Fe de Bogotá

Bogotá, Bogota D.C., Colombia

Hospital Departamental de Nariño

Nariño, Pasto, Colombia

Medicina Intensiva del Tolima

Ibagué, Tolima Department, Colombia

Clinica Reina Sofia

Bogotá, Colombia

Outcomes

Primary Outcomes

Hypoxemia

PO2 under 60mmHg, or SatO2 under 80%; that leads to the instauration of invasive ventilation

Time frame: 15 days

Tachypnea

Respiratory rate over 20; that leads to the instauration of invasive ventilation

Time frame: 15 days

Hypercapnia

PCO2 over 55mmHg; that leads to the instauration of invasive ventilation

Time frame: 15 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.